SanMelix Laboratories

company

About

SanMelix develops advanced homeopathic compositions efficient in the treatment of a variety of wound and dermal afflictions.

  • 1 - 10

Details

Last Funding Type
Non-Equity Assistant
Industries
Health Care,Home Health Care,Medical
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

SanMelix develops advanced homeopathic compositions efficiently in the treatment of a variety of wound and dermal afflictions.

The company develops its advanced wound healing therapeutics through understanding the natural mechanisms of action inherent in buckwheat honey, which produces improved clinical results. As a result of its research and development, SanMelix has patents pending for its unique therapeutic wound dressing compositions, BEECure products, which improve the efficacy of healing acute and chronic wounds.

It was founded by Dr. Kenneth A. Sabacinski, Diana Sabacinski, CPA, and John Kaufman in Hollywood, Florida in 2016.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
SanMelix Laboratories has raised a total of — in funding over 2 rounds. Their latest funding was raised on Oct 1, 2020 from a Non-Equity Assistant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 1, 2020 Non-Equity Assistant 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
SanMelix Laboratories is funded by 1 investors. Newchip are the most recent investors.
Investor Name Lead Investor Funding Round
Newchip Non-Equity Assistant